Literature DB >> 22643658

Surgical management of end-stage achalasia.

Daniela Molena1, Stephen C Yang.   

Abstract

Esophageal achalasia is a chronic and progressive motility disorder that leads to massive esophageal dilation when left untreated. Treatment for achalasia is palliative and aimed to relieve the outflow obstruction at the level of the lower esophageal sphincter, yet protecting the esophageal mucosa from refluxing gastric acids. The best way to accomplish this goal is through an esophageal myotomy and partial fundoplication, with a success rate >90%. Progression of disease, treatment failure, and complications from gastroesophageal reflux disease cause progressive deterioration of the esophageal function to an end stage in about 5% of patients. The only chance to improve symptoms in this small group of patients is through an esophageal resection. This article will review the indications for esophagectomy in end-stage achalasia, present the different types of surgical approach and possibilities for reconstruction of the alimentary tract, and summarize the short-term and long-term postoperative results.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22643658     DOI: 10.1053/j.semtcvs.2012.01.015

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  20 in total

Review 1.  Achalasia: current therapeutic options.

Authors:  Zubin Arora; Prashanthi N Thota; Madhusudhan R Sanaka
Journal:  Ther Adv Chronic Dis       Date:  2017-06-23       Impact factor: 5.091

2.  Safety and efficacy of using a short tunnel versus a standard tunnel for peroral endoscopic myotomy for Ling type IIc and III achalasia: a retrospective study.

Authors:  Longsong Li; Ningli Chai; Enqiang Linghu; Zhenjuan Li; Chen Du; Wengang Zhang; Jiale Zou; Ying Xiong; Xiaobin Zhang; Ping Tang
Journal:  Surg Endosc       Date:  2018-09-05       Impact factor: 4.584

3.  Outcomes after transhiatal esophagectomies in an eastern-European low-volume center.

Authors:  Radu Neagoe; Septimu Voidazan; Mihaly Szocs; Daniela Tatiana Sala; Serban Bancu; Gheorghe Mulhfay
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

Review 4.  Esophagectomy for benign disease.

Authors:  Jessica Mormando; Arianna Barbetta; Daniela Molena
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Hospitalization for esophageal achalasia in the United States.

Authors:  Daniela Molena; Benedetto Mungo; Miloslawa Stem; Anne O Lidor
Journal:  World J Gastrointest Endosc       Date:  2015-09-25

6.  POEM is a cost-effective procedure: cost-utility analysis of endoscopic and surgical treatment options in the management of achalasia.

Authors:  Heidi J Miller; Ruel Neupane; Mojtaba Fayezizadeh; Arnab Majumder; Jeffrey M Marks
Journal:  Surg Endosc       Date:  2016-08-17       Impact factor: 4.584

Review 7.  [Diagnostics and therapy of achalasia].

Authors:  B H A von Rahden; J Filser; F Seyfried; S Veldhoen; S Reimer; C-T Germer
Journal:  Chirurg       Date:  2014-12       Impact factor: 0.955

8.  Peroral endoscopic myotomy for advanced achalasia with sigmoid-shaped esophagus: long-term outcomes from a prospective, single-center study.

Authors:  Jian-Wei Hu; Quan-Lin Li; Ping-Hong Zhou; Li-Qing Yao; Mei-Dong Xu; Yi-Qun Zhang; Yun-Shi Zhong; Wei-Feng Chen; Li-Li Ma; Wen-Zheng Qin; Ming-Yan Cai
Journal:  Surg Endosc       Date:  2014-12-10       Impact factor: 4.584

9.  Laparoscopic Heller's cardiomyotomy: a viable treatment option for sigmoid oesophagus.

Authors:  Karthik Panchanatheeswaran; Rajinder Parshad; Jitender Rohila; Anoop Saraya; Govind K Makharia; Raju Sharma
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-10-12

10.  Outcomes of esophagectomy for esophageal achalasia in the United States.

Authors:  Daniela Molena; Benedetto Mungo; Miloslawa Stem; Richard L Feinberg; Anne O Lidor
Journal:  J Gastrointest Surg       Date:  2013-08-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.